Malaga Cove Capital, LLC Vertex Pharmaceuticals Inc Transaction History

Malaga Cove Capital, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$177.01 - $223.45 $1.4 Million - $1.77 Million	-7,905 Closed	0 $0
Q3 2021 Nov 05, 2021	BUY	$181.39 - $202.99 $9,069 - $10,149	50 Added 0.64%	7,905 $1.43 Million
Q2 2021 Jul 27, 2021	BUY	$187.49 - $221.1 $437,226 - $515,605	2,332 Added 42.22%	7,855 $1.58 Million
Q1 2021 May 07, 2021	BUY	$207.02 - $241.31 $177,002 - $206,320	855 Added 18.32%	5,523 $1.19 Million
Q4 2020 Feb 05, 2021	BUY	$207.01 - $276.09 $368,684 - $491,716	1,781 Added 61.69%	4,668 $1.08 Million
Q3 2020 Nov 03, 2020	BUY	$255.65 - $303.1 $6,646 - $7,880	26 Added 0.91%	2,887 $786,000
Q2 2020 Jul 29, 2020	BUY	$225.48 - $295.8 $15,783 - $20,706	70 Added 2.51%	2,861 $831,000
Q1 2020 May 15, 2020	SELL	$199.77 - $247.81 $181,191 - $224,763	-907 Reduced 24.53%	2,791 $663,000
Q3 2019 Oct 31, 2019	BUY	$166.23 - $187.09 $614,718 - $691,858	3,698 New	3,698 $627,000

1,716

225M

1.19M

1.56M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Malaga Cove Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Malaga Cove Capital, LLC with notifications on news.